AbbVie Appears Ready To Move Higher

Last August, I wrote an article arguing that AbbVie (NYSE: ABBV ) appeared overbought and ripe for a short-term period of moving sideways, or even testing support. In particular, I proposed that ABBV was still a good company, but that share performanceZvi provides advisory services to companies, trusts, and individuals, including consulting expert services regarding retirement and estate planning. Zvi is admitted to practice law in the state of New York, where he offers cash management, Bitcoin, and Trust P ...